SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : NewsEdge (NEWZ = INDV + DTOP) -- Ignore unavailable to you. Want to Upgrade?

To: Truman H. Jordan who wrote (2282)12/10/1999 1:28:00 PM
From: Ms. Baby Boomer  Read Replies (1) | Respond to of 2365
 
Correction Reply #2274 should read 10-Q's overlooked, sorry. I agree with Reg's sentiment, NEWZ has an offer from ROWE for .26 share. That particular YHOO press release based the offer on a valuation of ROWE's stock price on 12/6 which calculates to be approximately $13.00 or $227M. There's a lot going on behind the scenes with XML and OASIS, and NEWZ is in a very good position to benefit in the B2B enterprise market imho. Who knows what can develop.

Appreciate the heads-up.



To: Truman H. Jordan who wrote (2282)12/13/1999 10:29:00 AM
From: Ms. Baby Boomer  Respond to of 2365
 
Truman, took a quick look at the insider section for both ROWE & NEWZ, and there seems to be no indication that Basil Regan has an association with ROWE from those filings. There's a pending list of 144's (Form 144: Intention To Sell Restricted Securities) for ROWE though.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News